Steris (FRA:2TG) Net Current Asset Value: €-10.25 (As of Mar. 2026)


FRA:2TG Steris PLC FRA:2TG
85 GF Score
Price €188.90
GF Value €233.09
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Steris Net Current Asset Value?

Steris FRA:2TG +7.94% 85 Net Current Asset Value is €-10.25 as of Mar. 2026. GuruFocus rates FRA:2TG with a GF Score™ of 85/100 and a GF Value™ of €233.09 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 569 Medical Devices & Instruments companies, Steris ranks worse than 175746.75% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Steris's net current asset value per share for the quarter that ended in Mar. 2026 was €-10.25.

The historical rank and industry rank for Steris's Net Current Asset Value or its related term are showing as below:

FRA:2TG's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.99
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Steris  (FRA:2TG) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Steris Net Current Asset Value Related Terms


Steris Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for Steris's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris Net Current Asset Value Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.33 -25.88 -17.61 -14.52 -10.25

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.52 -12.24 -11.25 -10.01 -10.25

FRA:2TG vs ZBH, DXCM, PEN: Net Current Asset Value Comparison

For the Medical Devices subindustry, Steris's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Steris's Price-to-Net-Current-Asset-Value falls into.


FRA:2TG
85GF Score
Steris PLC FRA:2TG
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris Net Current Asset Value Calculation

Steris's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Mar. 2026 is calculated as

Net Current Asset Value Per Share(A: Mar. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(2071.329-3062.1-11.764-0)/97.800
=-10.25

Steris's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2026 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(2071.329-3062.1-11.764-0)/97.800
=-10.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of €-10.25 mean?
Steris (FRA:2TG) has a Net Current Asset Value of €-10.25 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Steris and its competitors. According to the industry distribution chart, Steris ranks #999999 out of 569 companies in the Medical Devices & Instruments industry.
Is Steris' Net Current Asset Value too high?
Steris' current Net Current Asset Value is €-10.25. Based on the distribution chart, Steris ranks #999999 out of 569 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Steris has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' Net Current Asset Value compare to ZBH and DXCM?
According to the Medical Devices & Instruments industry distribution chart, Steris ranks #999999 out of 569 companies for Net Current Asset Value. This places Steris in the lower half of its industry. The industry median Net Current Asset Value is 4.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Steris and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steris's current Net Current Asset Value is €-10.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (FRA:2TG) is currently considered Modestly Undervalued. The stock's GF Value™ is €233.09, compared to a current price of €188.90 — trading 19% below its estimated fair value. The current Net Current Asset Value is €-10.25. Steris' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Steris (FRA:2TG), the current Net Current Asset Value is €-10.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (FRA:2TG) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of €188.90 is trading 19% below its estimated GF Value™ of €233.09. GuruFocus considers Steris to be Modestly Undervalued.

Key valuation signals for FRA:2TG:

  • Net Current Asset Value: €-10.25
  • GF Value™: €233.09 vs. price of €188.90 (19% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the FRA:2TG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Steris Business Description

Other Exchanges STE:USAS1TE34:Brazil
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
85GF Score

Get the complete analysis for FRA:2TG

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€188.90
Price
€233.09
GF Value